Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Appointed director
Quarterly results
Director departure

ACHILLION PHARMACEUTICALS INC (ACHN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
02/03/2020 EFFECT Form EFFECT - Notice of Effectiveness:
02/03/2020 EFFECT Form EFFECT - Notice of Effectiveness:
02/03/2020 EFFECT Form EFFECT - Notice of Effectiveness:
02/03/2020 EFFECT Form EFFECT - Notice of Effectiveness:
01/30/2020 4 G1 EXECUTION SERVICES, LLC (10% Owner) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed of 10,917 shares @ $6.3, valued at $68.8k
Disposed of 14,115,498 shares @ $6.3, valued at $88.9M
01/30/2020 3 G1 EXECUTION SERVICES, LLC (10% Owner) has filed a Form 3 on ACHILLION PHARMACEUTICALS INC
01/29/2020 4 VITULLO NICOLE (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 36,431 shares @ $6.3, valued at $229.5k
Disposed/sold 3,393,382 shares @ $6.3, valued at $21.4M
Disposed/sold 25,159 shares @ $6.3, valued at $158.5k
Disposed/sold 50,000 options to buy @ $3.1, valued at $155k
Disposed/sold 20,000 options to buy @ $7.59, valued at $151.8k
Disposed/sold 20,000 options to buy @ $8.64, valued at $172.8k
Disposed/sold 25,000 options to buy @ $3.02, valued at $75.5k
Disposed/sold 25,000 options to buy @ $13.24, valued at $331k
Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
01/29/2020 4 Zelenkofske Steven (EVP, Chief Medical Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 500,000 options to buy @ $2.49, valued at $1.2M
Disposed/sold 200,000 options to buy @ $2.18, valued at $436k
01/29/2020 4 Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
Disposed/sold 42,000 options to buy @ $2.18, valued at $91.6k
01/29/2020 4 VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 40,000 shares @ $6.3, valued at $252k
Disposed/sold 20,000 options to buy @ $7.59, valued at $151.8k
Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 50,000 options to buy @ $3.1, valued at $155k
Disposed/sold 25,000 options to buy @ $3.02, valued at $75.5k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
Disposed/sold 42,000 options to buy @ $2.18, valued at $91.6k
01/29/2020 4 Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 3,500 shares @ $6.3, valued at $22.1k
Disposed/sold 142,000 options to buy @ $7.61, valued at $1.1M
Disposed/sold 100,000 options to buy @ $7.59, valued at $759k
Disposed/sold 185,000 options to buy @ $4.11, valued at $760.4k
Disposed/sold 632,000 options to buy @ $3.78, valued at $2.4M
Disposed/sold 30,000 options to buy @ $3.66, valued at $109.8k
Disposed/sold 87,766 options to buy @ $3.1, valued at $272.1k
Disposed/sold 200,000 options to buy @ $3.02, valued at $604k
Disposed/sold 419,000 options to buy @ $2.9, valued at $1.2M
Disposed/sold 1,097,000 options to buy @ $2.18, valued at $2.4M
01/29/2020 4 Scheer David (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 29,515 shares @ $6.3, valued at $185.9k
Disposed/sold 63,249 shares @ $6.3, valued at $398.5k
Disposed/sold 20,000 options to buy @ $7.59, valued at $151.8k
Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 50,000 options to buy @ $3.1, valued at $155k
Disposed/sold 25,000 options to buy @ $3.02, valued at $75.5k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
Disposed/sold 42,000 options to buy @ $2.18, valued at $91.6k
01/29/2020 4 MANNING MARTHA E (General Counsel) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 2,500 shares @ $6.3, valued at $15.8k
Disposed/sold 215,000 options to buy @ $2.9, valued at $623.5k
Disposed/sold 150,000 options to buy @ $2.18, valued at $327k
Disposed/sold 110,000 options to buy @ $6.79, valued at $746.9k
Disposed/sold 135,000 options to buy @ $4.11, valued at $554.9k
01/29/2020 4 KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 25,000 options to buy @ $3.02, valued at $75.5k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
Disposed/sold 6,250 options to buy @ $2.74, valued at $17.1k
Disposed/sold 42,000 options to buy @ $2.18, valued at $91.6k
01/29/2020 4 Graves Kurt (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 22,709 shares @ $6.3, valued at $143.1k
Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 135,000 options to buy @ $6.12, valued at $826.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 25,000 options to buy @ $3.02, valued at $75.5k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
Disposed/sold 42,000 options to buy @ $2.18, valued at $91.6k
01/29/2020 4 Gibney Anthony S (EVP, Chief Business Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 500,000 options to buy @ $2.53, valued at $1.3M
Disposed/sold 200,000 options to buy @ $2.18, valued at $436k
01/29/2020 4 FISHERMAN JASON S (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 90,000 shares @ $6.3, valued at $567k
Disposed/sold 1,500 shares @ $6.3, valued at $9.5k
Disposed/sold 20,000 options to buy @ $7.59, valued at $151.8k
Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 50,000 options to buy @ $3.1, valued at $155k
Disposed/sold 25,000 options to buy @ $3.02, valued at $75.5k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
Disposed/sold 42,000 options to buy @ $2.18, valued at $91.6k
01/29/2020 4 Firuta Paul E (EVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 400,000 options to buy @ $3.32, valued at $1.3M
Disposed/sold 200,000 options to buy @ $2.18, valued at $436k
01/29/2020 4 Di Donato Brian (SVP, CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 200,000 options to buy @ $2.56, valued at $512k
Disposed/sold 500,000 options to buy @ $2.29, valued at $1.1M
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/28/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy